Status:

COMPLETED

Rewards for Tuberculosis Contact Screening

Lead Sponsor:

Boston University

Collaborating Sponsors:

University of Witwatersrand, South Africa

City of Johannesburg

Conditions:

Tuberculosis

Drug-resistant Tuberculosis

Eligibility:

All Genders

Phase:

NA

Brief Summary

This pilot project is an evaluation of the feasibility, acceptability, and cost of offering an economic reward, in the form of a shopping voucher, to the household contacts of index patients (outpatie...

Detailed Description

Despite the success of antiretroviral treatment (ART) programs in reaching \> 10 million HIV-infected patients in resource-limited countries over the past decade, HIV and tuberculosis (TB), continue t...

Eligibility Criteria

Inclusion

  • Inclusion criteria for index cases:
  • Adult patients (\>18 years)
  • Newly diagnosed with pulmonary TB (drug-susceptible or drug-resistant) or initiating treatment for TB at one of the study sites
  • Exclusion criteria for index cases:
  • Resident outside the site's permissible catchment area for service delivery
  • No household contacts (live alone)
  • Admitted for inpatient care immediately following their TB diagnosis, and thus not readily able to distribute the referral cards
  • Not physically, mentally, or emotionally able to participate in the study, in the view of study staff
  • Previously enrolled in the same study
  • Declines to provide written informed consent to participate
  • Unable to speak any of the languages for which consent documents are available and not accompanied by person who can
  • Inclusion criteria for contacts:
  • Usually spend at least 4 nights per week in the same household as an index case
  • Can provide referral card given to contact by index patient
  • Exclusion criteria for contacts:
  • Currently on any type of TB treatment
  • Not able to present any form of identification that matches the information on the referral card
  • Previously enrolled in the same study
  • Declines to provide written informed consent to participate
  • Unable to speak any of the languages for which consent documents are available and not accompanied by person who can
  • Inclusion criteria for interview respondents:
  • Experience with the intervention as provider or patient
  • Written informed consent to be interviewed
  • Exclusion criteria for contacts:
  • • None

Exclusion

    Key Trial Info

    Start Date :

    October 1 2014

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 1 2016

    Estimated Enrollment :

    301 Patients enrolled

    Trial Details

    Trial ID

    NCT02234908

    Start Date

    October 1 2014

    End Date

    December 1 2016

    Last Update

    January 8 2021

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Helen Joseph Hospital

    Johannesburg, South Africa, 2193

    2

    OR Tambo Clinic

    Johannesburg, South Africa